Episode 183

Should You Get a P-Tau217 Biomarker Test?

In this episode of The Truth, Lies & Alzheimer’s Podcast, Lisa Skinner explores the growing conversation around the p-tau217 blood biomarker test and its potential role in identifying Alzheimer’s-related biological changes.

P-tau217 can provide valuable information about the likelihood of Alzheimer’s-related amyloid and tau pathology, but a result is not the same as a dementia diagnosis and cannot predict exactly if or when symptoms will develop.

Lisa discusses:

  • What the p-tau217 biomarker test measures
  • What a positive or negative result may mean
  • Why results should not be viewed as a guarantee or prediction of the future
  • The importance of symptoms, medical history, other testing, and clinical evaluation
  • Questions to consider before deciding to be tested
  • How testing may help provide direction for next steps rather than simply another number

The key question may not be just, “Should I get tested?” but rather, “What am I hoping to learn, and what will I do with the information?”

Hashtags

#Alzheimers #Dementia #DementiaCare #PTau217 #AlzheimersResearch #Biomarkers #MemoryLoss #BrainHealth #CognitiveHealth #DementiaAwareness #CaregiverSupport #TheTruthLiesAndAlzheimers

About the Podcast

Show artwork for Truth, Lies & Alzheimer's
Truth, Lies & Alzheimer's

About your host

Profile picture for Lisa Skinner, CDP, CDT

Lisa Skinner, CDP, CDT

Lisa Skinner is a dementia educator, author, speaker, and the founder of Minding Dementia. She helps families and caregivers better understand dementia, respond to changing behaviors, and approach care with greater confidence, compassion, and a person-centered perspective. On the podcast, Lisa shares practical education, expert conversations, and real-world guidance to help make the dementia journey feel a little less overwhelming.